YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Hundreds may join EpiPen class-action suit

Posted online
Hundreds are expected to join a class-action suit over allegations that Mylan unfairly increased the price of its EpiPen product.

“We have probably close to 1,000 people that have reached out to us. Social media is unbelievable. Facebook, Twitter. It’s been blowing up. I thought it would just be Ohio but it’s all over the country,” Cincinnati lawyer Carl Lewis told Fox Business.

Mylan, which owns EpiPen, has hiked the price from $57 in 2007 to more than $600 for a pack of two today.

Read more from Fox Business.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences